Apotea

The Nomination Committee proposes that Cecilia Qvist, Anders Eriksson, Joanna Hummel, Jonas Hagströmer, Monica Lindstedt, Per Schlingmann and Pär Svärdson are re-elected as members of the Board of Directors of Apotea. Furthermore, the Nomination Committee proposes re-election of Cecilia Qvist as Chairman of the Board. Maria Curman and Henrik Forsberg Schoultz have informed the Nomination Committee that they decline re-election. The Nomination Committee's proposal means that the number of Board members will be reduced from nine to seven.

All of the Nomination Committee's proposals will be presented in the notice to the Annual General Meeting and the proposals and the reasoned statement for the proposed composition of the Board of Directors will also be available on the company's website at the same time.

The Nomination Committee for the 2025 Annual General Meeting consists of Camilla Günesli appointed by Laulima AB, Chair of the Nomination Committee, Daniel Kristiansson appointed by Alecta Tjänstepension Ömsesidigt, Björn Henriksson appointed by Nordea fonder, Christopher Beaven appointed by WCM Investment Management, and Cecilia Qvist, Chair of the Board.

For further information, please contact:
Stefan Eriksson, deputy CEO & Investor Relations, e-mail: ir@apotea.se

About Apotea
Apotea is Sweden’s leading online pharmacy by market share with the goal of becoming the largest pharmacy in Sweden and hence also in the Nordics. With the widest assortment on the market, low prices and quick deliveries, Apotea facilitates everyday life for its three million active customers. In E-barometern’s 2024 customer survey, Apotea was ranked as customers’ favourite e-commerce store for the seventh consecutive year. Since 2022, the group also operates in Norway through its Norwegian subsidiary Apotera.